A detailed history of Graham Capital Management, L.P. transactions in Care Dx, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 15,323 shares of CDNA stock, worth $328,218. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,323
Holding current value
$328,218
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $220,804 - $520,828
15,323 New
15,323 $478,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $847,566 - $1.39 Million
52,775 New
52,775 $898,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.